Clinical Trial

Reduction of Anxiety in People With Disabilities Through Dual Treatment: Digital CBT & NBHWC Coaching - A Randomized Clinical Trial

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to see if a mobile-delivered mental health program called Toivoa-001, which combines digital cognitive behavioral therapy (CBT) with personal mental health coaching, can effectively reduce anxiety in adults with hearing or mobility disabilities. The study aims to answer whether this dual-intervention digital service is more effective at lowering anxiety symptoms over an 8-week period than a "sham" digital program that is developed to look similar but does not contain active therapeutic content. The investigators hypothesize that participants who use the Toivoa-001 program will show significantly greater reductions in anxiety compared to those using the sham program, and that these mental health benefits will last through a 12-week follow-up. Adults within the disability community frequently encounter unique environmental and societal barriers - such as limited physical accessibility, transportation challenges, and workplace inflexibility - that can directly drive or worsen anxiety. By offering a fully remote and accessible mobile tool, this study seeks to determine if a digital health service can deliver scalable, effective anxiety relief tailored to the lived experiences of people with disabilities.
Protocol Amendment History 3 changes
critical Primary endpoint(s) modified 2026-07-21
notable Primary completion pushed: 2027-03 -> 2027-08 2026-07-07
minor Completion pushed: 2027-03 -> 2027-08 2026-07-07
Trial Details
NCT Number NCT07140497
Lead Sponsor Toivoa Inc
Collaborators: Delaware State University, VA New Jersey Health Care System, South Texas Veterans Health Care System, Louis Stokes VA Medical Center
Conditions Hearing Disability, Anxiety, Mobility Disability
Enrollment 200 participants
Start Date 2026-08
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-20